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1. Introduction 
The benzodiazepine tranqulllising drugs are believed 
to produce their pharmacological effects by affect- 
ing synaptic processes [l] but the exact site and 
mode of this action remain unknown. However, the 
binding of [3H]diazepam to rat [2,3] and human 
[4] brain membranes has been demonstrated; its
affinity and those calculated for other drugs in the 
series were shown to correspond to their clinical 
effectiveness [2,4]. An approach to identifying such 
a putative membrane receptor is to solubilise it in 
non-ionic detergent medium; this facilitates its bio- 
chemical analysis, as has proven fruitful with the 
peripheral nicotinic acetylcholine receptor [5]. We 
show here that the benzodiazepine-binding struc- 
ture (provisionally referred to as the receptor) can 
be obtained in such a soluble condition with reten- 
tion of its ligand binding activity and specificity. 
Evidence bearing upon its molecular constitution is 
also given. 
2. Materials and methods 
2.1. Gtemicals 
[N-meth~Z-3H]Diazepam (47 Ci/mmol) and 
[N-merhyl-3H]flunitrazepam (3 1 Cilmmol) were 
from the Radiochemical Centre, Amersham. Their 
unlabelled versions were gifts from Roche Products 
Ltd. Leupeptin and pepstatin were kindly provided 
by the USA-Japan Coop. Cancer Res. Prog. Triton 
X-100 was from Rohm and Haas, and all the other 
chemicals from Sigma. 
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2.2. Preparation of brain membranes and their solubi- 
lisation 
Whole brain cortex was removed from Sprague- 
Dawley rats (-2.50 g body wt) and homogenised in
10 vol. ice-cold sucrose (0.32 M) containing protease 
inhibitors [6], i.e., 1 mM EDTA, 10 Erg/ml leupeptin, 
10 pg/rnl pepstatin, 200 pgg/ml bacitracin, 1 mM 
benzamidine-HCl, 0.1 mM phenylmethane sulphonyl 
fluoride (PMSF) and 20 pgg/ml soybean trypsin 
inhibitor. The homogenate was centrifuged at 
2 X lo4 g . min; the pellet (Pr) was discarded and the 
supematant was recentrifuged at either 1.5 X lo6 g . min 
(for P2 fraction) or 6 X lo6 g . min (for Pz + Pa). 
The membranes were lysed by resuspension i  0.05 M 
Tris-HCl (pH 7.4) containing the inhibitors (as above). 
The receptor was either assayed in the membrane- 
bound state or solubilised by adding Triton X-100 to 
the final concentration oted in the text (using 8 ml 
medium/g original tissue wet wt), followed by brief 
homogenisation (Polytron; setting 4 (maximal setting 
is 10) for 20 s) and shaking for 1 h at 4°C. The resul- 
tant extract was spun at 6 X lo6 g . min. The super- 
natant and pellets (the latter redispersed in 0.05 M 
Tris-HCl buffer, pH 7.4) were assayed for [3H]ligand 
binding. In some cases the membranes were treated 
by a modification of the method reported [7] to 
remove an endogenous protein inhibitor: the lysed P? 
fraction was frozen and stored for 1 day at -2O”C, 
thawed, extracted in 0.01% Triton X-100 at 4°C for 
10min and centrifuged at 1.5 X lo6 g . min, before 
extraction as above. Protein contents were determined 
[S] on all samples (after complete solubilisation i  
0.75 M NaOH) by the Folin-Lowry method. 
2.3, Benzodiazepine binding assays 
The binding assay on membranes (lysed Pz , or 
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PZ t Pa, fraction) followed fairly closely that in [2], 
using an initial incubation at 22°C (15 min) and a 
final one at 4°C (30 min), but without dilution of 
the suspension thereafter before applying it to a 
glass fibre filter and then washing with 2 X 5 ml ice- 
cold 0.05 M Tris-HCI buffer (pH 7.4). For assays on 
the solubilised fraction, the samples were diluted with 
extraction medium so as to contain < 1 mg protein/ml 
and [3H]ligand was added (to the concentration 
stated), with incubation for 15 min at room tempera- 
ture and then on ice for 30 min. Samples (100 /.d) 
were then applied to Whatman DE81 filters which 
were held in a PVC washing assembly (joined to a 
vacuum manifold) designed to give free access of wash 
liquid up to the edge of the filter disc. After 4 min for 
equilibration suction was applied and then 2 washes, 
each with 10 ml icecold 0.05 M Tris-HCl buffer 
(pH 7.4) containing 0.2% Triton X-100, were given 
rapidly. The filters were dried and the radioactivity 
counted by liquid scintillation at 30-35% efficiency, 
using a toluene-based mixture [ 51 containing 10% 
Soluene (Packard). The specific binding was the total 
binding minus the non-specific binding; the latter was 
measured with the unlabelled ligand (3 I.IM for diaze- 
pam and 20 PM for flunitrazepam) present in the 
incubation medium. AI1 samples were incubated in 
triplicate. 
3. Results 
3 .I . Binding sites in brain membranes 
Specific binding of [3H] diazepam to rat brain 
membranes was observed and the findings [2,3] were 
confnmed: at pH 7.4 (4°C) the sites in the crude 
synaptosomal (lysed PZ) membrane fraction (or that 
plus the microsomal fraction P3) exhibited a dissocia- 
tion constant (Kd) of 3.4 (? 0.6) nM, with the drug, 
for a single, saturable class of sites as seen in the 
Scatchard plot (using [‘Hldiazepam at G 100 nM). 
Studies with [3H]flunitrazepam [8,9] also gave evi- 
dence for a single, specific, high affinity (Kd 6 nM) 
binding site (fig.1, insert). The values found from 
Scatchard plots (table 1, lines 1,2) agree fairly well 
withthe results& 2.5-5.3 nM; 0.81-I -45 pmol/mg 
protein) of similar measurements made with diazepam 
on rat or human membranes [3,4,10]. However, others 
[8,9] have observed alower specific activity (0.1-0.5 
pmol/mg protein) but higher affinity (K,- 1 nM) for 
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Fig.1. Binding of [‘HI diazepam to cortex membrane frac- 
tion (p, + P,) solubilised in 0.7% Triton X-100. Each point 
is the mean of triplicates, expressed as fmol bound/100 ~1 
extract. The lower curve shows the control points for non- 
specific binding (i.e., in the presence of 3 nM u&belled 
diazepam); the upper curve represents the specific binding 
obtained after correction for that control. Insert: Scatchard 
plot for the specific binding of [ 3H] flunitrazepam to cortex 
membrane fraction (P,), intact (o), or after solubllisation in 
0.7% Triton X-100 (0). 
flunitrazepam in rat brain membranes. The binding of 
flunitrazepam and diazepam found here were mutually 
exclusive, again indicating aspecific site. 
3.2. Solubilisation 
Homogenisation and shaking of the membranes in
the detergent Triton X-l 00 was able to extract 
actively-binding material into solution: the extent of 
this increased up to -0.7% (v/v), and was then con- 
stant up to 2% detergent ( able 2, column 2). Exten- 
sion of the period of extraction to 3 h or to 15 h 
did not increase the yield. It was necessary to add 
inhibitors of proteases, using a set of these recently 
found effective in preventing proteolysis of cholin- 
esterases inTriton X-100 extractions of muscle [6]; 
when these were omitted the extracted receptor mea- 
sured was much less, and when partly omitted a 
partial decrease occurred (table 2, column 3). 
The assay used relies upon the retention of the 
Table 1 
Binding of [ 3H]flunitrazepam by rat cortex membranes (P,) and by their 0.7% 
Triton X-l 00 extracts 
Receptor state Kd (nM)a pmol/mg protein 
At 20 nM ligandb At satn.a 
Membrane bound: 
unwashed 6 f 0.1 2.1 2.7 f 0.07 
washedC 6 f 0.2 2.2 
Solubilised 12 + 0.4d 
2.6 f 0.14 
1.1 1.8d f 0.06 
a The mean f SEM of values derived from the slopes and the intercepts of 
Scatchard plots, as illustrated in fig.1, from 4 separate xperiments 
b Values are the means from 2 independent experiments, each using pooled tissues 
from 3 rats 
c In these experiments the membranes were (after centrifugation but prior to sub- 
sequent extraction) initially frozen, stored for 1 day at -2O’C, thawed and 
washed with 0.01% Triton X-100 at 4°C for 10 min. Values not significantly 
different from these were obtained when fresh (not freeze-thawed) membranes 
were extracted similarly in 0.01% Triton X-100 
d The membranes used for extraction were frozen, thawed and washed as noted in c. 
However, identical values were obtained in a parallel experiment using mem- 
branes which were not pretreated in this manner 
Table 2 
Extract of benzodiazepine binding sites from the membranes 
into aqueous detergent solutions 
Triton X-lOOa 
(%) 
Relative binding (soluble)b 
Protected Unprotected 
0.1 0.02 0 
0.3 0.36 - 
0.5 0.83 0.32 
0.7 1.00 0.59 
1.5 0.97 0.35 
2.0 0.93 0.33 
a The membrane fraction was extracted for 1 h at 4°C with 
Triton X-l 00 present at the fiial concentration shown 
b The relative binding of [ ‘Hlbenzodiazepine (under stan- 
dard conditions) in the solubihsed fraction, taking the 
value found in the extraction in 0.7% Triton X-100 as the 
reference 
Assays were with 24 nM [3H]flunitrazepam of [aH]diazepam; 
the measured radioactivity corresponding to the relative value 
1.0 was -1000 cpm (specific binding)/assay. The mean for 
two independent extractions (each using 3-5 rats) is given. 
For the experiments of the second column, the full set of 
protease inhibitors listed under section 2 was present through- 
out. In the experiments of the last column, much less protec- 
tion was given (leupeptin, bacitracin, PMSF and benzamidine 
were omitted), resulting in decreased yields of active binding 
sites. Separate xperiments using membranes howed that 
none of the protease inhibitors used reduced the binding of 
[ ‘Hlflunitrazepam in the standard assay conditions 
solubilised acidic membrane proteins, but not free 
benzodiazepines, on a DEAE-cellulose disc, as applied 
[5] to the muscle acetylcholine receptor. Saturable 
binding of [ 3H] diazepam and [3H] flunitrazepam to 
the solubilised receptor was observed. The non-specific 
background (taken as the binding in the presence of a 
large excess of the unlabelled ligand) was a con- 
veniently small fraction of the total; values found with 
< 40 nM [3H]diazepam are shown in fig.1, and for 
[3H]flunitrazepam, the non-specific background was 
always still lower. 
Scatchard plots (as in fig. 1, insert) again showed a 
single class of benzodiazepine binding sites in the 
soluble extract; the affinity for either ligand was 
reduced in the soluble form to 12 nM. The total 
recovery of the membrane binding sites in the solu- 
blised form was 60-70% after a single detergent treat- 
ment , when calculated for the total number of sites 
at saturation with ligand in each case. Excess diazepam 
or flunitrazepam inhibited the binding of the other 
ligand (table 3). 
Pretreatment of the membranes by freezing, 
thawing and washing in 0.01% Triton X-100, was 
recently described as removing an endogenous protein 
inhibitor of [3H]diazepam binding to brain mem- 
branes [7]. This was also applied here (table 1): the 
very dilute detergent wash step removed no receptor 
and did not increase the detectable number of 
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receptor sites in the membranes. The specific activity, 
with or without this pretreatment, was reduced in 
the solubilisation to -66% of the washed membrane 
value (table 1). 
3.3. Molecular properties of the solubilised component 
The specific binding activity was completely stable 
for > 1 day at 4°C. On brief exposure to heat it was 
abolished, and the same was true after a short treat- 
ment with either of two proteases (table 3). The 
action of trypsin here could be completely blocked 
by trypsin inhibitors; as expected the action of pro- 
nase was not affected. Incubation with phospho- 
lipase AZ had no effect (table 3). Hence, the soluble 
binding activity appears to depend upon the integrity 
of a protein. 
Sucrose density centrifugation of the active extract 
was performed to estimate the molecular size of the 
receptor. Lysed PZ membranes from fresh rat brain 
Table 3 
Effects of various different treatments upon the binding 
of [sH]benzodiazepines to detergent-solubilised receptor 
Treatment Cont. Bindinga 
(% control) 
None (control) 
Flunitraze amb 
g Diazepam 
Trypsin (1 h, 37°C) 
Inactivated trypsinC 
Treated pronaseC 
Phospholipase Ad 
65oC, 5 min 
9O”C, 1 min 
_ 100% 
3 X 1O-6 M 1% f 1% 
3 X lo+ M 4% + 3% 
0.03% 5% 
0.03% <I% 
0.03% <l% 
109 U/ml 95% 
_ <l% 
- <l% 
a The treatments were applied in 0.5% Triton X-100/0.05 M 
Tris-HCl (pH 7.4), prior to the standard assay (using 
24 nM [ 3H]flunitrazepam). For the treatments at 37”C, the 
control was also incubated at 37”C, for 1 h prior to assay. 
In the control 4300 cpm represented the 100% values 
b Present during the assay; when the flunitrazepam was pres- 
ent 5 nM [ ‘Hjdiazepam was used for the assay of tests and 
controls 
’ The protease (used again here at 37’C, 1 11) had been, to 
inactivate trypsin, pretreated (37“C, 30 min) with a 30-fold 
excess of soybean trypsin inhibitor, or with lOWa M DFP 
(for trypsin, second value) as a further control 
d Phospholipase A, from bee venom plus 20 mM CaCl, was 
present tar 1 h at 3?C prior to the binding measurement; 
the activity of this same sample of enzyme was determined 
using egg lecithin as substrate 
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Fig.2. Density gradient sedimentation of the solubilised 
benzodiazepine-binding component. A 5-20% sucrose gra- 
dient was run as described [ 61 but with the sucrose made 
up in 0.5% Triton X-100/0.05 M Tris-HCl (pH 7.4). Frac- 
tions of 230 ~1 were collected, and 200 ~1 from each was 
taken for [“Hlflunitrazepam binding assay. Standards run in 
parallel were horse liver alcohol dehydrogenase (A), beef liver 
catalase (C) and Escherichia coli p-galactosidase (G); their 
~20 w values are plotted (in S) in the calibration plot (insert) 
used to determine the ~20,~ value at the receptor peak maxi- 
mum (P). 
were extracted and immediately applied to the gra- 
dient which contained 0.5% Triton X-100. Assays of 
all of the fractions revealed a single peak of activity 
centered at s20,w = 12.8 S (fig.2); a slight shoulder at 
15 S was also observed. 
4. Discussion 
The solubilisation of the membrane-bound benzo- 
diazepine binding component in a stable and active 
state opens up the way to its purification. Affinity 
chromatographic methods for this should be feasible. 
The possibility of the blockade by endogenous ligands 
of some of the binding sites in the membrane [7] was 
avoided by the pre-treatment with very dilute deter- 
gent, but the amounts of such inhibitors initially pres- 
ent probably are insufficient to interfere with benzo- 
diazepine binding in the soluble state. The extent of 
receptor solubilisation is high; ligand affinities of the 
receptor in the presence of the solubilising detergent 
are about one-half of that in the membrane. 
The evidence presented here indicates that a pro- 
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tein with s20 w = 12.8 S (when in detergent solution) 
is the benzodiazepine receptor. 
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